Establishment of a multi-specific monoclonal antibody MsMab-1 recognizing both IDH1 and IDH2 mutations

Tohoku Journal of Experimental Medicine

Volumn 230, Issue 2, 2013, Pages 103-109

  Kaneko, Mika Kato ^a   Ogasawara, Satoshi ^a   Kato, Yukinari ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Isocitrate dehydrogenase 1; Isocitrate dehydrogenase 2; Monoclonal antibody; Multi specific; Mutations

Indexed keywords

ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE 2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MSMAB 1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; ISOCITRATE DEHYDROGENASE 1 GENE; ISOCITRATE DEHYDROGENASE 2 GENE; MOUSE; MUTATIONAL ANALYSIS; NEOPLASM; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; WESTERN BLOTTING;

AMINO ACIDS; ANIMALS; ANTIBODIES, MONOCLONAL; ARGININE; BRAIN NEOPLASMS; CHO CELLS; CODON; CRICETULUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; ISOCITRATE DEHYDROGENASE; MICE; MUTATION; PEPTIDES; RECOMBINANT PROTEINS;

EID: 84879333828     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.230.103     Document Type: Article

References (25)

1. Amary, M.F., Damato, S., Halai, D., Eskandarpour, M., Berisha, F., Bonar, F., McCarthy, S., Fantin, V.R., Straley, K.S., Lobo, S., Aston, W., Green, C.L., Gale, R.E., Tirabosco, R., Futreal, A., Campbell, P., Presneau, N. & Flanagan, A.M. (2011) Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat. Genet., 43, 1262-1265.
2. Balss, J., Meyer, J., Mueller, W., Korshunov, A., Hartmann, C. & von Deimling, A. (2008) Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol., 116, 597-602.
3. Capper, D., Zentgraf, H., Balss, J., Hartmann, C. & von Deimling, A. (2009) Monoclonal antibody specific for IDH1 R132H mutation. Acta Neuropathol., 118, 599-601.
4. Dang, L., White, D.W., Gross, S., Bennett, B.D., Bittinger, M.A., Driggers, E.M., Fantin, V.R., Jang, H.G., Jin, S., Keenan, M.C., Marks, K.M., Prins, R.M., Ward, P.S., Yen, K.E., Liau, L.M., Rabinowitz, J.D., Cantley, L.C., Thompson, C.B., Vander Heiden, M.G. & Su, S.M. (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature, 462, 739-744.
5. Dinardo, C.D., Propert, K.J., Loren, A.W., Paietta, E., Sun, Z., Levine, R.L., Straley, K.S., Yen, K., Patel, J.P., Agresta, S., Abdel-Wahab, O., Perl, A.E., Litzow, M.R., Rowe, J.M., Lazarus, H.M., Fernandez, H.F., Margolis, D.J., Tallman, M.S., Luger, S.M. & Carroll, M. (2013) Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia. Blood, 121, 4917-4924.
6. Hartmann, C., Meyer, J., Balss, J., Capper, D., Mueller, W., Christians, A., Felsberg, J., Wolter, M., Mawrin, C., Wick, W., Weller, M., Herold-Mende, C., Unterberg, A., Jeuken, J.W., Wesseling, P., Reifenberger, G. & von Deimling, A. (2009) Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol., 118, 469-474.
7. Ikota, H., Nobusawa, S., Tanaka, Y., Yokoo, H. & Nakazato, Y. (2011) High-throughput immunohistochemical profiling of primary brain tumors and non-neoplastic systemic organs with a specific antibody against the mutant isocitrate dehydrogenase 1 R132H protein. Brain Tumor Pathol., 28, 107-114.
8. Kaneko, M.K., Tian, W., Takano, S., Suzuki, H., Sawa, Y., Hozumi, Y., Goto, K., Yamazaki, K., Kitanaka, C. & Kato, Y. (2011) Establishment of a novel monoclonal antibody SMab-1 specific for IDH1-R132S mutation. Biochem. Biophys. Res. Commun., 406, 608-613.
9. Kaneko, M.K., Tsujimoto, Y., Hozumi, Y., Goto, K. & Kato, Y. (2013a) Novel monoclonal antibodies GMab-r1 and LMab-1 specifically recognize IDH1-R132G and IDH1-R132L mutations. Monoclon. Antib. Immunodiagn. Immunother., 32, 224-228.
10. Kaneko, M.K., Morita, S., Tsujimoto, Y., Yanagiya, R., Nasu, K., Sasaki, H., Hozumi, Y., Goto, K., Natsume, A., Watanabe, M., Kumabe, T., Takano, S. & Kato, Y. (2013b) Establishment of novel monoclonal antibodies KMab-1 and MMab-1 specific for IDH2 mutations. Biochem. Biophys. Res. Commun., 432, 40-45.
11. Kato, Y., Jin, G., Kuan, C.T., McLendon, R.E., Yan, H. & Bigner, D.D. (2009) A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation. Biochem. Biophys. Res. Commun., 390, 547-551.
12. Kato, Y. & Kaneko, M.K. (2013) Generation of a novel monoclonal antibody WMab-1 specific for IDH2-R172W mutation. Biochem. Biophys. Res. Commun., 433, 374-378.
13. Kato, Y. Natsume, A. & Kaneko, M.K. (2013) A novel monoclonal antibody GMab-m1 specifically recognizes IDH1-R132G mutation. Biochem. Biophys. Res. Commun., 432, 564-567.
14. Kolker, S., Pawlak, V., Ahlemeyer, B., Okun, J.G., Horster, F., Mayatepek, E., Krieglstein, J., Hoffmann, G.F. & Kohr, G. (2002) NMDA receptor activation and respiratory chain complex V inhibition contribute to neurodegeneration in d-2-hydroxyglutaric aciduria. Eur. J. Neurosci., 16, 21-28.
15. Pansuriya, T.C., van Eijk, R., d'Adamo, P., van Ruler, M.A., Kuijjer, M.L., Oosting, J., Cleton-Jansen, A.M., Oosterwijk, J.G., van Verbeke, S.L., Meijer, D., van Wezel, T., Nord, K.H., Sangiorgi, L., Toker, B., Liegl-Atzwanger, B., San-Julian, M., Sciot, R., Limaye, N., Kindblom, L.G., Daugaard, S., Godfraind, C., Boon, L.M., Vikkula, M., Kurek, K.C., Szuhai, K., French, P.J. & Bovee, J.V. (2011) Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat. Genet., 43, 1256-1261.
16. Parsons, D.W., Jones, S., Zhang, X., Lin, J.C., Leary, R.J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.M., Gallia, G.L., Olivi, A., McLendon, R., Rasheed, B.A., Keir, S., Nikolskaya, T., Nikolsky, Y., Busam, D.A., Tekleab, H., Diaz, L.A. Jr., Hartigan, J., Smith, D.R., Strausberg, R.L., Marie, S.K., Shinjo, S.M., Yan, H., Riggins, G.J., Bigner, D.D., Karchin, R., Papadopoulos, N., Parmigiani, G., Vogelstein, B., Velculescu, V.E. & Kinzler, K.W. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science, 321, 1807-1812.
17. Paschka, P., Schlenk, R.F., Gaidzik, V.I., Habdank, M., Kronke, J., Bullinger, L., Spath, D., Kayser, S., Zucknick, M., Gotze, K., Horst, H.A., Germing, U., Dohner, H. & Dohner, K. (2010) IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication. J. Clin. Oncol., 28, 3636-3643.
18. Rohle, D., Popovici-Muller, J., Palaskas, N., Turcan, S., Grommes, C., Campos, C., Tsoi, J., Clark, O., Oldrini, B., Komisopoulou, E., Kunii, K., Pedraza, A., Schalm, S., Silverman, L., Miller, A., Wang, F., Yang, H., Chen, Y., Kernytsky, A., Rosenblum, M.K., Liu, W., Biller, S.A., Su, S.M., Brennan, C.W., Chan, T.A., Graeber, T.G., Yen, K.E. & Mellinghoff, I.K. (2013) An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. Science, 340, 626-630.
19. Sonoda, Y., Kumabe, T., Nakamura, T., Saito, R., Kanamori, M., Yamashita, Y., Suzuki, H. & Tominaga, T. (2009) Analysis of IDH1 and IDH2 mutations in Japanese glioma patients. Cancer Sci., 100, 1996-1998.
20. Struys, E.A., Salomons, G.S., Achouri, Y., Van Schaftingen, E., Grosso, S., Craigen, W.J., Verhoeven, N.M. & Jakobs, C. (2005) Mutations in the D-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria. Am. J. Hum. Genet., 76, 358-360.
21. Takano, S., Kato, Y., Yamamoto, T., Kaneko, M.K., Ishikawa, E., Tsujimoto, Y., Matsuda, M., Nakai, K., Yanagiya, R., Morita, S., Tsuboi, K. & Matsumura, A. (2012) Immunohistochemical detection of IDH1 mutation, p53, and internexin as prognostic factors of glial tumors. J. Neurooncol., 108, 361-373.
22. von Deimling, A., Korshunov, A. & Hartmann, C. (2011) The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutations. Brain Pathol., 21, 74-87.
23. Wang, F., Travins, J., DeLaBarre, B., Penard-Lacronique, V., Schalm, S., Hansen, E., Straley, K., Kernytsky, A., Liu, W., Gliser, C., Yang, H., Gross, S., Artin, E., Saada, V., Mylonas, E., Quivoron, C., Popovici-Muller, J., Saunders, J.O., Salituro, F.G., Yan, S., Murray, S., Wei, W., Gao, Y., Dang, L., Dorsch, M., Agresta, S., Schenkein, D.P., Biller, S.A., Su, S.M., de Botton, S. & Yen, K.E. (2013) Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation. Science, 340, 622-626.
24. Ward, P.S., Patel, J., Wise, D.R., Abdel-Wahab, O., Bennett, B.D., Coller, H.A., Cross, J.R., Fantin, V.R., Hedvat, C.V., Perl, A.E., Rabinowitz, J.D., Carroll, M., Su, S.M., Sharp, K.A., Levine, R.L. & Thompson, C.B. (2010) The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell, 17, 225-234.
25. Yan, H., Parsons, D.W., Jin, G., McLendon, R., Rasheed, B.A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G.J., Friedman, H., Friedman, A., Reardon, D., Herndon, J., Kinzler, K.W., Velculescu, V.E., Vogelstein, B. & Bigner, D.D. (2009) IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med., 360, 765-773.